Clinigen Group PLC (LON:CLIN) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as low as $937.50. Clinigen Group shares last traded at $984.00, with a volume of 89,589 shares trading hands.

Separately, Peel Hunt restated a “buy” rating and issued a GBX 60 ($0.78) target price on shares of Renewi in a research note on Wednesday, July 3rd.

The company has a market capitalization of $1.30 billion and a PE ratio of 49.22. The company has a 50-day moving average of GBX 1,014.77. The company has a debt-to-equity ratio of 56.71, a quick ratio of 1.32 and a current ratio of 1.54.

Clinigen Group Company Profile (LON:CLIN)

Clinigen Group plc operates as a specialty pharmaceutical and services company. The company operates through three segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires and licenses commercial medicines and then revitalises them, as well as provides access to licensed and branded generic medicines in the Africa and Asia Pacific region.

Featured Story: Stochastic Momentum Index (SMI)

Receive News & Ratings for Clinigen Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group and related companies with's FREE daily email newsletter.